Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
16.46
-0.17 (-1.02%)
At close: Feb 21, 2025, 4:00 PM
16.57
+0.11 (0.67%)
After-hours: Feb 21, 2025, 4:00 PM EST
Fulgent Genetics Employees
Fulgent Genetics had 1,184 employees as of December 31, 2023. The number of employees increased by 172 or 17.00% compared to the previous year.
Employees
1,184
Change (1Y)
172
Growth (1Y)
17.00%
Revenue / Employee
$234,595
Profits / Employee
-$139,332
Market Cap
503.46M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
FLGT News
- 16 days ago - Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025 - Business Wire
- 18 days ago - Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics - Business Wire
- 2 months ago - Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside - Seeking Alpha
- 3 months ago - Fulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fulgent Reports Third Quarter 2024 Financial Results - Business Wire
- 3 months ago - Fulgent to Participate in Upcoming Conferences - Business Wire
- 4 months ago - Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1 - Business Wire
- 4 months ago - Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024 - Business Wire